Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

PharmEasy

Health Tech & Medtech · Mumbai, India · Founded 2015 · IPO 2021 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$5.60B
Market cap · 2026
Revenue
$705M
Latest reported FY
Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Online pharmacy, diagnostics, and teleconsultation healthcare platform.

Investors

25 investors on PharmEasy's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Bessemer Venture Partners
Series B+ 24 investors entered at this stage
Prosus
Tiger Global
Think Investments
TPG Growth
Orios Venture Partners
KB Financial Group
TPG
CDPQ
ADQ
ApaH Capital
Temasek
Kotak Private Equity
Neuberger Berman
Fundamentum
Prosus Ventures
B Capital
Sanne Group
Steadview Capital
OrbiMed
Eight Roads Ventures
Amansa Holdings
Janus Henderson Investors
LGT Capital Partners
Lightrock

PharmEasy mafia

Startups founded by PharmEasy alumni

Former PharmEasy employees who went on to start their own companies. Sorted by Dealroom signal score.

SwishEst. 2024
Saran SIndia
Signal score95
Beacon.liEst. 2023
Rakesh VaddadiUnited States
Signal score83
CoverSureEst. 2023
Mayank MishraIndia
Signal score73
Two words DesignEst. 2019
RVRakesh VermaIndia
Signal score65
SolvoEst. 2021
GBGaurav BajajUnited Kingdom
Signal score55
MyPickupEst. 2022
Abhijeet JagtapIndia
Signal score51
DopplrEst. 2020
Vishal DagaIndia
Signal score44

Book a demo to explore the full alumni network →

Global footprint

Where PharmEasy has talent and traffic

Workforce by country
20 countries with
team presence
🇮🇳 India96.9%
🇦🇪 United Arab Emirates0.4%
🇺🇸 United States0.4%
🇪🇬 Egypt0.3%
🇨🇦 Canada0.2%
Top 5 of 20 shown
Web traffic by country
9.4M monthly visits
across markets
🇮🇳 India92.9%
🇺🇸 United States1.2%
🇬🇧 United Kingdom0.5%
🇵🇰 Pakistan0.4%
🇦🇪 United Arab Emirates0.3%
Top 5 markets shown

Capital deployed

PharmEasy's 4 investments and acquisitions.

Every disclosed deal where PharmEasy appeared as a backer or acquirer, 2021–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across PharmEasy's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        PharmEasy's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Sentiment on X

        What X is saying about PharmEasy

        An AI-synthesized read of the highest-engagement posts about PharmEasy on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See PharmEasy on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles